Literature DB >> 18570007

What role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population.

Astri Medbø1, Hasse Melbye.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an under-diagnosed condition. General practitioners meet and examine the patients in early stages of the disease, and symptoms represent the starting point of the diagnostic process. AIM: To evaluate the diagnostic value of respiratory symptoms in the diagnosis of airflow limitation.
METHODS: Spirometry was performed in a cross-sectional population-based study of 3954 subjects 60 years and older (54.5% women), who also filled in a questionnaire on symptoms.
RESULTS: The prevalence of any airflow limitation was 15.5% and 20.8%, in women and men, respectively, whereas the corresponding prevalence of severe airflow limitation (FEV(1)<50% predicted) was 3.4% and 4.9%. The positive predictive value of chronic cough with phlegm for any airflow limitation was 37.0% in women and 40.4% in men, and 17.3% and 14.2%, respectively, for severe airflow limitation. Wheezing was a symptom which persisted despite smoking cessation, whereas coughing was considerably less common in ex-smokers than in current smokers. Wheezing, dyspnoea on unhurried walking, dyspnoea on quick walking, and coughing with phlegm were independent predictors of any airflow limitation, OR 1.5, 1.8, 1.4, and 1.6 respectively. (The ORs for severe airflow limitation were 2.4, 2.4, 2.4, and 1.6 respectively.) To be an ex-smoker (OR 2.4) or a current smoker (OR 5.8) was of greater importance. In never- and ex-smokers the chance of having airflow limitation was almost doubled when having two or more, compared with one, of the three symptoms: wheezing, dyspnoea, and coughing with phlegm. Ex-smokers reporting two symptoms had a similar risk of airflow limitation to current smokers not reporting any symptoms.
CONCLUSION: Respiratory symptoms are valuable predictors of airflow limitation and should be emphasized when selecting patients for spirometry.

Entities:  

Mesh:

Year:  2008        PMID: 18570007      PMCID: PMC3406655          DOI: 10.1080/02813430802028938

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  25 in total

1.  Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study.

Authors:  A Langhammer; R Johnsen; A Gulsvik; T L Holmen; L Bjermer
Journal:  Eur Respir J       Date:  2001-11       Impact factor: 16.671

2.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

3.  Health outcomes assessment and economic evaluation in COPD: challenges and opportunities.

Authors:  S D Sullivan; A S Buist; K Weiss
Journal:  Eur Respir J Suppl       Date:  2003-06

4.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

5.  Does the clinical examination predict airflow limitation?

Authors:  D R Holleman; D L Simel
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

6.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

7.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

8.  Undiagnosed patients and patients at risk for COPD in primary health care: early detection with the support of non-physicians.

Authors:  Hubertus J M Vrijhoef; Joseph P M Diederiks; Geertjan J Wesseling; Constant P van Schayck; Cor Spreeuwenberg
Journal:  J Clin Nurs       Date:  2003-05       Impact factor: 3.036

9.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.

Authors:  J A Hardie; A S Buist; W M Vollmer; I Ellingsen; P S Bakke; O Mørkve
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

10.  Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

Authors:  Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

View more
  17 in total

1.  Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study.

Authors:  Tuula Toljamo; Marjo Kaukonen; Pentti Nieminen; Vuokko L Kinnula
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

2.  The use of ethnically specific norms for ventilatory function in African-American and white populations.

Authors:  P G J Burney; R L Hooper
Journal:  Int J Epidemiol       Date:  2012-03-19       Impact factor: 7.196

3.  Do symptoms predict COPD in smokers?

Authors:  Jill A Ohar; Alireza Sadeghnejad; Deborah A Meyers; James F Donohue; Eugene R Bleecker
Journal:  Chest       Date:  2010-04-02       Impact factor: 9.410

4.  Identifying adults at risk of COPD who need confirmatory spirometry in primary care: Do symptom-based questions help?

Authors:  Kylie Hill; Richard Hodder; Maria Blouin; Diane Heels-Ansdell; Gordon Guyatt; Roger Goldstein
Journal:  Can Fam Physician       Date:  2011-02       Impact factor: 3.275

5.  Decline in air pollution and change in prevalence in respiratory symptoms and chronic obstructive pulmonary disease in elderly women.

Authors:  Tamara Schikowski; Ulrich Ranft; Dorothee Sugiri; Andrea Vierkötter; Thomas Brüning; Volker Harth; Ursula Krämer
Journal:  Respir Res       Date:  2010-08-22

6.  High prevalence of emphysema and its association with BMI: a study of smokers with normal spirometry.

Authors:  Georgios Stratelis; Sven-Göran Fransson; Birgitta Schmekel; Per Jakobsson; Sigvard Mölstad
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

7.  Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies.

Authors:  MeiLan K Han; Anna W Steenrod; Elizabeth D Bacci; Nancy K Leidy; David M Mannino; Byron M Thomashow; R G Barr; Barry J Make; Russ P Bowler; Stephen I Rennard; Julia F Houfek; Barbara P Yawn; Catherine A Meldrum; John W Walsh; Fernando J Martinez
Journal:  Chronic Obstr Pulm Dis       Date:  2015

8.  Sputum colour for diagnosis of a bacterial infection in patients with acute cough.

Authors:  Attila Altiner; Stefan Wilm; Walter Däubener; Christiane Bormann; Michael Pentzek; Heinz-Harald Abholz; Martin Scherer
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

9.  The efficacy of spirometry as a screening tool in detection of air flow obstruction.

Authors:  Nabeel Manzar; A Suleman Haque; Bushra Manzar; Muhammad Irfan
Journal:  Open Respir Med J       Date:  2010-09-23

10.  Respiratory symptoms and peripheral airways disease in a cross-sectional study on a random population sample.

Authors:  Jan Yngve Olofson; Birgitta Houltz; Maria Nilsson Tengelin; Björn Bake
Journal:  BMJ Open       Date:  2012-11-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.